Tara Pemberton, PA
Medical · Portland, ORNPI 1275803462
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,955 of the $2,206 with a category attached, or 88.6%. It is spread thinly across 19 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $919, 7.3 times the $126 reported in 2021.
Across 89 payments — averaging $24.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$440
- Sanofi$435
- Regeneron Healthcare Solutions, Inc.$318
- AbbVie$143
- Biocryst US Sales Co., LLC$143
- GSK$102
- plus $626 from 13 others
What the payments were for
- Food & beverage$1,95589%
- Education$25211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 28 | $440 |
| Sanofi | 20 | $435 |
| Regeneron Healthcare Solutions, Inc. | 8 | $318 |
| AbbVie | 2 | $143 |
| Biocryst US Sales Co., LLC | 2 | $143 |
| GSK | 4 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Genentech USA, Inc. | 4 | $84 |
| AstraZeneca | 3 | $66 |
| Novartis | 4 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| Alk-abello, Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Ionis Pharmaceuticals, Inc. | 1 | $38 |
| Blueprint Medicines Corporation | 1 | $34 |
| Pfizer | 2 | $33 |
| Incyte Corporation | 1 | $26 |
| Pharming Healthcare, Inc. | 1 | $21 |
| Merck | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,206 in reported general payments places this provider in the 85th percentile of 364 medical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 18 | $50,138 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $15,964 |
| Qvar RedihalerBeclomethasone Dipropionate | 18 | $9,975 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $5,768 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,587 |
| Arnuity ElliptaFluticasone Furoate | 14 | $3,600 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $731 |
| Azelastine Hcl | 22 | $557 |
| Montelukast Sodium | 36 | $435 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $102 | $25,33150 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 364 medical providers in Oregon.
Other medical in Portland
- Britt BennPortland$11K
- Erica BallardPortland$8K
- Kimberly SandersPortland$5K
- Cody BallardPortland$4K
- Margaret NgPortland$4K
- Dmitriy ShorePortland$3K
- Bridget LahmPortland$3K
- Mary TeggerPortland$3K
- Maureen BaileyPortland$3K
- Kelly WulfPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.